AsiaPharm Group Ltd.

Napo Pharmaceuticals Completes Dose Selection Phase of ADVENT Trial.
AIDS Weekly; 8/17/2009; 1397 words; ...blind, parallel-group, placebo-controlled...treatment for three dose groups (125 mg, 250 mg, and...daily), and a placebo group, totaling approximately...Glenmark Pharmaceuticals, Ltd. in India plus 140 emerging...ingredient (API). AsiaPharm Group, Ltd. has licensed rights...

Napo Pharmaceuticals Receives Biotech Humanitarian Award Nomination.
AIDS Weekly; 5/18/2009; 825 words; ...diarrhea ( CRO-PED ) with Glenmark Pharmaceuticals, Ltd. in over 140 emerging and developing countries outside North America, Japan, China and the EU ( ROW ); AsiaPharm Group for the same indications in China; and, Salix Pharmaceuticals...

AsiaPharm Group Ltd.-Company Report.
M2 Presswire; 2/9/2009; 498 words; ...www.companiesandmarkets.com: AsiaPharm Group Ltd.-Company Report(C)1994-2009 M2 COMMUNICATIONS LTD RDATE:09022009 -www.companiesandmarkets.com adds new report: AsiaPharm Group Ltd.-Company Report Private...

Napo Pharmaceuticals Announces Publication of Paper on Crofelemer for Indication of Irritable Bowel Syndrome.
Business Wire; 12/23/2008; 1331 words; ...collection. Napo has collaborations with Salix Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited of India and AsiaPharm Group Ltd. of China. For more information please visit www.napopharma.com.

Napo Presents at ISPOR Meeting in Toronto.
PR Newswire; 5/12/2008; 922 words; ...may be in-licensed from other sources. Napo has partnerships with Glenmark Pharmaceuticals Limited of India and AsiaPharm Group Ltd. of China. For more information please visit http://www.napopharma.com/. About ISPOR ISPOR promotes...